Methemoglobinemia

DBCOND0001602Congenital, Hereditary, and Neonatal Diseases and AbnormalitiesHemic and Lymphatic Diseases

Methemoglobinemia is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Also known as
Methaemoglobinaemia
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0013565ICD-10D74SNOMED CT191386007MedDRA10027496UMLSC0025637

What you can answer from here — as of October 22, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
10Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Contraindicated drugsDrugs whose labels contraindicate them in this condition
Sign in
3Boxed warningsLabel boxed warnings that name this condition
Sign in
28Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Methemoglobinemia share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In